As use continues to grow, emergency physicians will encounter these medications more frequently across a broader patient population
High-precision remote monitoring responds to this concern and rises to the challenge, as it provides: Accurate and consistent collection of blood pressure, weight, body composition, and other key metrics from the comfort of the patients home Automatic transmission of this data to the patients care team Swift provider insight into patient well-being so patterns can be identified and medications or care plans can be adjusted Better patient/provider communication and shared-decision making Moving Forward In this new era of GLP-1 medications, official scientific guidelines from organizations such as the ADA, EASD, AACE, ACC, and AHA recommend regular monitoring of blood pressure in patients on GLP-1 therapies as part of comprehensive cardiovascular risk management
I cannot function until I take my capsules, ESPECIALLY when random TEST alerts wake you up at 4:45AM
Both should be reconstituted with bacteriostatic water, refrigerated at 2-8C, and used within 28 days
regional disease prevalence The results (see chart and full report in [2]): MAC policies matter most for: - Aflibercept (Eylea) for macular degeneration - 53% MAC-driven - Buprenorphine ER for opioid dependence - 30% MAC-driven Geography matters most for: - Alpha-1 Proteinase for genetic COPD - 125% regional - Chemotherapy nausea drugs - 100% regional The pattern: Controlled and expensive drugs show strong MAC influence
PubMed Shen W, et al